BNP Paribas Asset Management
PRCT icon

BNP Paribas Asset Management’s Procept Biorobotics PRCT Stock Holding History

BNP Paribas Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.8M Sell
2,823,849
-265,529
-9% -$6.65M 0.06% 286
2026
Q1 		$77.3M Sell
3,089,378
-5,271
-0.2% -$149K 0.09% 230
2025
Q4 		$97.4M Buy
3,094,649
+2,002,389
+183% +$66.4M 0.11% 180
2025
Q3 		$39M Buy
1,092,260
+308,047
+39% +$14.1M 0.1% 216
2025
Q2 		$45.2M Buy
784,213
+440,702
+128% +$24.9M 0.11% 192
2025
Q1 		$20M Sell
343,511
-151,206
-31% -$10.3M 0.05% 345
2024
Q4 		$39.8M Sell
494,717
-15,936
-3% -$1.36M 0.1% 217
2024
Q3 		$40.9M Sell
510,653
-9,297
-2% -$660K 0.1% 206
2024
Q2 		$31.8M Sell
519,950
-107,872
-17% -$6.42M 0.08% 240
2024
Q1 		$31M Buy
627,822
+51,305
+9% +$2.44M 0.08% 248
2023
Q4 		$24.2M Buy
576,517
+17,492
+3% +$596K 0.07% 272
2023
Q3 		$18.3M Buy
559,025
+335,472
+150% +$11.4M 0.06% 305
2023
Q2 		$7.9M Buy
+223,553
New +$7.39M 0.02% 442

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BNP Paribas Asset Management's PRCT Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Procept Biorobotics (PRCT) stake by 8.6% in Q2 2026, selling an estimated $6.65M and leaving 2,823,849 shares worth $63.8M. The position accounts for 0.06% of the portfolio, ranked #286.

BNP Paribas Asset Management first reported a position in PRCT in Q2 2023 and has held it in 13 quarters since. The position peaked at $97.4M in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • BNP Paribas Asset Management held 2,823,849 shares of Procept Biorobotics worth $63.8M as of Q2 2026.
  • BNP Paribas Asset Management sold 265,529 Procept Biorobotics shares in Q2 2026, an estimated $6.65M.
  • Procept Biorobotics made up 0.06% of BNP Paribas Asset Management's portfolio in Q2 2026, its #286 holding.
  • BNP Paribas Asset Management first reported a position in Procept Biorobotics in Q2 2023 and has held it in 13 quarters since.
  • BNP Paribas Asset Management's Procept Biorobotics position peaked at $97.4M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.